Lotus Eye Hosp Peer Comparison

NSE: LOTUSEYE | BSE: 532998

₹110.66

₹1.60 (1.47%)

As on 08-Sep-2026IST

Market cap

₹228 Cr

Revenue (TTM)

₹57 Cr

P/E Ratio

1520.9

P/B Ratio

3.8

Div. Yield

0 %

Edit

	Lotus Eye Hosp	Aspira Pathlab	Dr. Agarwal's Health Care	Dr. Lal Pathlabs	Global Health	Krishna Institute	NG	Samsrita Labs	Soni Medicare	Vijaya Diagno
Market cap (₹ Cr)	228	100	16,482	32,085	38,377	32,131	39	27	30	15,484
Revenue (₹ Cr)	57	26	2,207	2,891	4,683	4,213	17	0	24	857
Net Profit (₹ Cr)	0.15	-0.45	185.10	546.30	552.34	190.80	1.93	-8.72	-3.62	187.49
Net Margin (%)	0.26	-1.72	8.25	18.23	11.55	4.49	10.69	-17,442.00	-15.36	21.32
RoE (%)	0.26	-3.41	7.47	23.03	14.93	9.45	5.30	-60.02	--	20.58
Price to Earnings	1,520.90	--	111.09	59.21	69.00	157.27	20.06	--	--	82.59
Price-To-Book	3.76	8.17	7.97	12.28	9.33	8.49	1.14	2.34	-11.34	15.37

Income Statement (₹ Cr)

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Operating Revenue	57.25	25.90	16.90	23.53	0.02
Total Income	58.45	26.43	18.03	23.53	0.05
Total Expenditure	52.40	24.92	15.02	25.19	8.77
EBITDA	4.85	0.99	1.88	-1.66	-8.75
Depreciation	4.57	1.58	0.57	0.52	0.00
EBIT	0.28	-0.59	1.31	-2.18	-8.75
Interest	1.25	0.39	0.06	1.36	0.00
Other Income	1.20	0.53	1.13	0.00	0.03
Exceptional Items	-0.01	0.00	0.00	0.00	0.00
Profit before Tax	0.23	-0.45	2.38	-3.54	-8.72
Provision for Tax	0.08	0.00	0.45	0.08	0.00
Profit after Tax	0.15	-0.45	1.93	-3.62	-8.72

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Shareholder's Funds	60.14	12.23	33.56	-1.23	11.75
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	13.12	3.08	0.00	12.27	0.09
Current Liabilities	9.34	3.20	1.90	15.64	2.54
Total Liabilities	69.57	17.46	41.62	22.17	15.57

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Non-Current Assets	59.70	8.97	32.40	6.70	11.84
Current Assets	11.37	4.59	2.94	17.61	2.54
Total Assets	69.57	17.46	41.62	22.17	15.57
Total Debt*	0.61	1.21	1.78	10.52	2.43
Net Current Assets	2.03	1.39	1.04	1.97	0.01
Contingent Liabilities	0.82	1.12	0.09	0.03	--

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Cash From Operating Activities	2.70	1.83	1.81	1.47	-0.23
Cash Flow from Investing Activities	-3.99	0.12	-1.23	-0.52	--
Cash from Financing Activities	-1.60	-0.99	-0.62	-0.24	0.22
Net Cash Inflow / Outflow	-2.89	0.95	-0.03	0.71	0.00

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
ROCE (%)	3.10	19.27	23.83	6.58	-1.79
ROE (%)	0.26	-3.41	5.30	-12.79	-60.02
ROA (%)	0.20	-2.52	5.00	-14.80	-121.26
EBIT Margin (%)	0.50	-2.29	7.75	-9.26	-48,627.78
Net Margin (%)	0.26	-1.72	10.69	-15.36	-17,442.00
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	-4.85

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Revenue Growth (%)	14.08	14.56	2.15	-25.05	--
EBIT Growth (%)	-40.59	-123.61	16.96	-255.13	-4.35
Net Profit Growth (%)	-77.38	-117.74	-74.09	-1,029.31	-3.83
EPS Growth (%)	-76.43	-117.74	-74.09	-1,029.31	-8.58
Book Value Growth (%)	1.00	19.94	6.59	-19.64	-2.32

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Price / Earnings	1,473.29	-219.46	20.06	0.00	-3.29
Price / Book Value	3.76	8.17	1.14	15.72	2.34
Dividend Yield (%)	0.00	0.00	3.03	0.00	0.00
EV/EBITDA	46.32	99.90	20.14	22.85	-3.07
Market Cap (₹ Cr)	145.37	87.73	54.63	20.42	--

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Debt to Equity	0.17	0.11	0.00	-9.00	0.00
Short term debt to equity ratio	--	--	0.05	0.31	0.20
Current Ratio	1.22	1.43	1.55	1.13	1.00
Quick Ratio	0.81	1.22	1.12	1.07	1.00
Interest Coverage	1.18	-0.17	39.34	-1.61	-182.25

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Debtors to sales (%)	2.11	6.69	2.84	54.17	111.11
Asset Turnover	0.75	1.44	0.44	0.96	0.00
Receivable days	9.50	38.11	6.31	96.98	--
Inventory Days	25.93	7.95	15.24	8.69	--
Payable days	80.52	72.32	0.00	251.51	--
Cash Conversion Cycle	-45.09	-26.26	21.54	-145.84	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.